Table 1. Hsp90 and Her2 Tethered inhibitors.
Names, descriptive features and structures for compounds used in the study. The synthesis and detailed analysis of the compounds can be found in Figure S1.
| Designation name |
Feature | Structure |
|---|---|---|
| HS-10 | parent ligand |
|
| HS-23 | ligand + linker |
|
| HS-27 | ligand + FITC |
|
| HS-32 | bis-ferrocene |
|
| HS-42 | lapatinib + fluorescein |
|
| HS-66 | double ligand |
|
| HS-69 | ligand + nIR (645) |
|
| HS-70 | ligand + nIR (800) |
|
| HS-96 | ligand + biotin |
|
| HS-105 | FITC derivative w/o ligand |
|
| HS-111 | Iodine- containing ligand |
|